14
Page 1 of _ APR 13 2011 510(k) Summary This summary of safety and effectiveness information is being provided in accordance with the requirements of SMDA 1990 and 21 CFR 807.92. The assigned 5 1 0(k) number is:K K10 1201 Submitter's Information: Vitali Bondar, CEO FDA CDRH- DMC KAT Implants LLC 1 15 Rye Street, Suite 115 JAN~ 3 120111 Portsmouth, NH 03801 Phone: (603) 427-0084 Received Fax: (603) 427-0045 Date the Summary was Prepared: November 11, 2010 Device name: * Common Name: Endosseous Dental Implant, Root-form; Endosseous Dental Implant Abutment * Trade Name: KAT Implant System Dental Implant 6.0mmn x 6.0mm; Dental Implant 6.0mm x 8.0mm; Denta] Implant 6.0mmn x 10.0mm; Dental Implant 7.0mm x 6.0mm;- Dental Implant 7.0mm x 8.0mm; Dental Implant 7.0mm. k 10.0mm; Dental Implant 8.0mm, x 6.0mm; Dental Implant 8.0mm x 8.0mm; Dental Implant 8.0mm x 10O.0mm KAT Implant System Straight (Prepable) Abutments 4.2mm x 6.5mm, Straight (Prepable) Abutments 4.6mm. x 6.5mm, Straight (Prepable) Abutments 5.0mm x 6.5mm, Straight (Prepable) Abutments 5.4mm x 6.5mm, Straight (Prepable) Abutments 6.4mm x 6.5mm * Classification name: Endosseous Dental Implant (21 CER 872.3640, Product code DZE)

CDRH- DMC 1 · nitric acid passivation per ASTM F86-04, Standard Practice for Surface Preparation and Marking of Metallic Surgical Implants); d) packaged with the same size and material

  • Upload
    others

  • View
    8

  • Download
    0

Embed Size (px)

Citation preview

Page 1: CDRH- DMC 1 · nitric acid passivation per ASTM F86-04, Standard Practice for Surface Preparation and Marking of Metallic Surgical Implants); d) packaged with the same size and material

Page 1 of _

APR 1 3 2011510(k) Summary

This summary of safety and effectiveness information is being provided in

accordance with the requirements of SMDA 1990 and 21 CFR 807.92. Theassigned 5 1 0(k) number is:K K10 1201

Submitter's Information:

Vitali Bondar, CEO FDA CDRH- DMCKAT Implants LLC 115 Rye Street, Suite 115 JAN~ 3 120111Portsmouth, NH 03801Phone: (603) 427-0084 ReceivedFax: (603) 427-0045

Date the Summary was Prepared: November 11, 2010

Device name:

* Common Name:

Endosseous Dental Implant, Root-form; Endosseous Dental ImplantAbutment

* Trade Name:

KAT Implant System Dental Implant 6.0mmn x 6.0mm; Dental Implant6.0mm x 8.0mm; Denta] Implant 6.0mmn x 10.0mm; Dental Implant7.0mm x 6.0mm;- Dental Implant 7.0mm x 8.0mm; Dental Implant 7.0mm.k 10.0mm; Dental Implant 8.0mm, x 6.0mm; Dental Implant 8.0mm x8.0mm; Dental Implant 8.0mm x 10O.0mm

KAT Implant System Straight (Prepable) Abutments 4.2mm x 6.5mm,Straight (Prepable) Abutments 4.6mm. x 6.5mm, Straight (Prepable)Abutments 5.0mm x 6.5mm, Straight (Prepable) Abutments 5.4mm x6.5mm, Straight (Prepable) Abutments 6.4mm x 6.5mm

* Classification name:

Endosseous Dental Implant (21 CER 872.3640, Product code DZE)

Page 2: CDRH- DMC 1 · nitric acid passivation per ASTM F86-04, Standard Practice for Surface Preparation and Marking of Metallic Surgical Implants); d) packaged with the same size and material

*Classification Panel:

Dental

Device classification: Class 11

Indications for Use:

KAT Implant System Dental Implants are indicated for restoration of edentulous

maxilla and mandible, to provide support for removable dentures, fixed bridges,

or to be used as a single tooth replacement. Single or splinted implants can be

immediately loaded if good primary stability and appropriate occlusal loading are

achieved. The implants can be placed in extraction sites or healed alveolar ridges.

Immediate loading may not be appropriate in Type IV bone due to difficulty in

achieving Primary §stajbility.

KAT Implant System Straight Abutment devices are intended to be used with.

RAT Implant System Dental Implants to aid in prosthetic rehabilitation.

Removed transitional applications

RAT Implant System (Dental Implants and Straight Abutment) is indicated for

the restoration of edentulous areas in maxilla and mandible.

The legally marketed devices to which the equivalence is claimed

[807.92(a)(3)]:

Predicate device: RAT Implant System Dental Implant 5.0mm x 6.0mm; Dental

Implant 5.0mm x 8.0mm; Dental Implant 5.0mm x 10O.0mm

Applicant: RAT Implants, LLC

5 10(k) number: K083 544

Page 3: CDRH- DMC 1 · nitric acid passivation per ASTM F86-04, Standard Practice for Surface Preparation and Marking of Metallic Surgical Implants); d) packaged with the same size and material

Predicate device: KAT Implant System Implant (Indexed) Abutment 4.2mm x

6.5mm, Implant (Indexed) Abutment 4.7mm. x 6.5mm, Implant (Indexed)

Abutment 5.5mm x 6.5mm, Implant (Indexed) Abutment 6.5mm x 6.5mm

Applicant: KAT Implants, LLC

5 10O(k) number: K083544

Page 4: CDRH- DMC 1 · nitric acid passivation per ASTM F86-04, Standard Practice for Surface Preparation and Marking of Metallic Surgical Implants); d) packaged with the same size and material

Description of Devices:

KAT Implant System Dental Implants (with outside diameters 6.0mm, 7.0mm and

8.0mm) and KAT Implant System Straight (Prepable) Abutments (with outside

diameters 4.2mm, 4.6mm, 5.0mm, 5.4mm, and 6.4mm) are root-form, endosseous

dental implant and implant abutment devices intended to be distributed as part of

the KAT Implant System platform. KAT Implant System currently consists of

implants, abutments, and Class I accessory instrumentation cleared for marketing

under Traditional 510(k) Pre-marketing Notification # K083 544.

Like the predicate KAT Implant System Dental Implant with outside diameter

5.0mm, the KAT Implant System Dental Implants which are subject of this 5 10(k)

_______are provided in lengths of 6.0mm, 8.0mm, and 10.0mm. External V-shaped

thEad is simil1arly utilized in these new sie-f~ iir-RnS-stem*enta V'--

Implants in order to screw the implants into the bone. Horizontal fins are also

placed between the thread and the abutment receiving portion of these dental

implants. The abutment receiving portion of all KAT Implant System Dental

Implants consists of a 3.1mm outside diameter post with a 1.5 degree taper. All

KAT Implant System Dental Implants are intended to be used with previously

cleared KAT Implants System Implant Abutments, as stated in Instructions for

Use.

Like the predicate KAT Implant System Implant (Indexed) Abutments with

outside diameters 4.2mm, 4.7mm, 5.5mm and 6.5mm, the KAT Implant Straight

(Prepable) Abutments which are subject of this 5 10(k) consist of outside

diameters within the predicate's range of outside diameters, and are 6.5mm in

length. KAT Implant System Straight (Prepable) Abutments are similarly

retained by the KAT Implant System Dental Implants .through the abutment-

receiving post. A locking-taper connection activates the seating of the abutment

to the implant with the help of a torque wrench.

Page 5: CDRH- DMC 1 · nitric acid passivation per ASTM F86-04, Standard Practice for Surface Preparation and Marking of Metallic Surgical Implants); d) packaged with the same size and material

Like the predicate KAT Implant System Dental Implant and Implant Abutments,

KAT Implant System Dental Implants and Abutments which are subject of this

5 10(k) are manufactured:

a) using the same Titanium-6Aluminum-4Vanadium ELI alloy (certified to meet

ASTM Fl36-2(a), Standard Specification for Wrought Titanium-6Aluminum-

4 Vanadium ELIl loy for Surgical Implant Applications and biocompatibility

requirements of Class II Special Control Guidance Document: Root-form

Endosseous Dental Implants and Endosseous Dental Implant Abutments);

b) undergoes the same aluminum oxide grit-blasting (compliant with blasted

surfaces requirements of Class II Special Control Guidance Document: Root-

form Endosseous Dental Implants and Endosseous Dental Implant Abutments)

- -- and;

nitric acid passivation per ASTM F86-04, Standard Practice for Surface

Preparation and Marking of Metallic Surgical Implants);

d) packaged with the same size and material primary packaging (in conformnance

with material and process requirements of ISO 11607.2006, Packaging for

Terminally-Sterilized Medical Devices);

e) and are sterilized using the same sterilization process and sterility assurance

level with SAL = 10,6 (per 1S0 1113 7:2006, Sterilization of Healthcare

Products - Radiation)

Summary of similarities and modification between the devices which are subject of this

5 10(k) and predicate device is presented in the table below:

Page 6: CDRH- DMC 1 · nitric acid passivation per ASTM F86-04, Standard Practice for Surface Preparation and Marking of Metallic Surgical Implants); d) packaged with the same size and material

E U)

EE E -EE E E E E

E~ E I'D 0EE E

(0 a) (D 0

(D E~W E4E c) E2 E c )E-

LO 211 L6 E 6z-< c

LEE ~E E _d)

U) ~ ~ E 0ffff f

2 E 2) Cto:, o U) =1 EE E E t

- :3~z M__ __ _ C) A t O

EL __ E r-

2 E E~ E~ 0ELQ 4 u) 4

E 2o >, (D(nd2 2M (n ) 0 0

mzE O - m c 2E 0 )~

a__ (d c6 4 (6 - 5 -a 0

'IT - i; 0 _a

It (D E 0 a)2~ E 0i,.

y ) 0 ,I Lo )a)_aU) N L Lo. 0 c =

2zC5 - oL 6,i( 5i A: 2 a) m U

) 0-

E~ 0E- E E -520 E q 0 .2 cd E (D M

0 0)-0'

C) U)c (

o) EEE 0 )0)) '-

00 Qz a)0 0 'UCD C 06E q q. 0C

a)~ 00 cu 00 0 CD WOFO

Page 7: CDRH- DMC 1 · nitric acid passivation per ASTM F86-04, Standard Practice for Surface Preparation and Marking of Metallic Surgical Implants); d) packaged with the same size and material

m.fU( ( 0 >1

(0 m EwC U) 0)0) -2o i

co~ "0 E~ Q U) C0) CL.o 03c o oa>

m w~t 2 E (n moi L

-0- )= c " ) 3 a -) c -- 0 ) E )own oc (n -c C iE~ 0)>O

0- *0 m C: w 0 6 ): r0n 0) ") 0)

0i -. 0 a) -D Cfl (0L - 3 - E F- r_ - : 0(D ( 0 0

CLC)C~ 0- 0.0 0 u -9 C

0)U.) (0n (0( (D 0 :(-0 0) F- - (D Ul U

-0 (D (D >1 0))a) > .E-a 0- a) 0) u 0CC0.C )(D ) -rn)

0 0 W0 222'.00UU)m 0 M

--- -- M U - - - r - >,- C__ _ _ __ _ _ _ .-___ _

00 (n c 0) _r >( i6U ) o c 0 2 In) ) C > Ca)v -U) M M 0c Ec Sa - c~ -m0 =

a) a)0 co U)c in U) m ) E(c c cE)9 I) U) C: U

- ...( m~ 0- u E FM00)cCD 90o a) ~ T (00 C

L) CL-0 C:E U) E-0 i U-E( a) C

0 " a) 0 > C ) ' .0 0

00 () ' ( a -- BL- U)D )50 l Esu E LO0 U

(D - -EC:C 0 CL c ~E~L : -- 0( 60 )(D' '- =o j 0.-m .

0)0 c >15 0 U -

-m d)3' >1~. ) V ~ ~ ~ 0 (-' E a0.5( ( U) En ca U) )

4) m M 0 CD 0) CC

(n E) m ~ E -a V 2, E)E " nca)aC06a) m - L W( )U) ) c)M ) 0 (00 Cc .V) > U E -a L =) -0 . 0 0 4 ) 2k-

ID 0 c C 0 >1 i= -.- o c 0 0 -0'0 iU EMc Na 0 _

(D~0 CO00 h2 )C

Page 8: CDRH- DMC 1 · nitric acid passivation per ASTM F86-04, Standard Practice for Surface Preparation and Marking of Metallic Surgical Implants); d) packaged with the same size and material

6) cm E-0~~~6 a)' "- - C

~) =0 ~fJ66(D -- a D tm 0

.0 a) =5 ))

L) a) .a

CL C C ME.0 _r 00C0(D 0 (

>< 0DC)a)C ) )aW0 M *0 ca a) C

E c>1 0 w 6ncE L) .) c w 0 o ~ CLC -I ) L C

~c c V r.2 Er L0~66660 6) (26-c C ( E r

06) -0 E a)E

(6 C>0 a) -0 'n-C(4) m.. C6)(f'. ~ 06 W -0 0 6a

0 0)

0 2> r . 0 03 a- 6a0V6)U cn 0)C U 3 )

a)~~ >C>(DU

EE 6 u ) M7 o : 0 a o ca) 0 N-- w.L0 OC6)C)

X (D CEr a

((D6)M 0) :a

6) V) > .6) a)0=--0 ~ ~ ~ ~ ~ ~ ~ 6 o.c- c M- - )C

5< CD cb 2 Qu ao -0-.0 )a)a

06 ) a) Vo 0 U)=0 E 0Er

'a ~ ~ ~ a)Q)a-a-n(

L .0C Ca)

(D C6 T

o0 (D5(0 0- CL 0 L

.2 . u U~

>3.E 0 (D ,

X/O r- 10 =3 E -1D

Page 9: CDRH- DMC 1 · nitric acid passivation per ASTM F86-04, Standard Practice for Surface Preparation and Marking of Metallic Surgical Implants); d) packaged with the same size and material

a) a)E 0 E

0~ .0 0.aa

-U 2) -0=3 a) (D -0 ELE

Co C:>- 0- u:) 0U)E-=.-ca LO ca 0C- .Nc

D, -K C C0 C

a) a) E Ea0 C

--0) -" oo -aEE "

) c EHd) U E a~) a) U

(U -E -r- cnw ) (U) 0) U) 0

0 0)

(D E a) ECu 0 a~ ) o

(D- rC ,I--

'Ca E-" (D m a ) 15

-a) L (D CLu(

0 E0 cn CC E

U) 0) ~ ) * a

cmC O ~ C 2

a))C .0)-0

( a)

-oF E a))0 )~ (

a) E)~ a)C ~ ) -C) Cu

0u Ut0 0 a) -t ) V).. UM U 2 >)%

cm a) 0 a)--C '2a 0 -0.-" c D 0

(D )0 a) C t 0

a) m -0 m) U) UQ-,o~~~~C a) :30 MUU C ) 0

... .a) :3 Q 0 0

0m r - )C

Z .2a)).C z.0m)ECo0a)

.0C(D -r- aO)D0 qa = : d )r

- C .- N -Ca) L DC(r E a ( a) (DEa

0 ~ ~ ~ a 0, m 0> a pE --0 C u0 -c0wmL

a) (c.:

0 a-

Page 10: CDRH- DMC 1 · nitric acid passivation per ASTM F86-04, Standard Practice for Surface Preparation and Marking of Metallic Surgical Implants); d) packaged with the same size and material

ch

.- M t

(D)- 2)

0 c~

n ..-

a) E c

r- E~ -0

c E C:0

Page 11: CDRH- DMC 1 · nitric acid passivation per ASTM F86-04, Standard Practice for Surface Preparation and Marking of Metallic Surgical Implants); d) packaged with the same size and material

Summary of the non-clinical test submitted as part of this submission:

Testing performed on Implant/Abutment System as presented in Section 18, Performiance

Testing - Bench yield results indicating similar threshold in applied forces as the

predicate that could affect co-axial implant/abutment rotation when used as instructed.

Conclusions Drawn:

The following devices listed in this pre-marketing notification:

a) KAT Implant System Dental Implant 6.0mm x 6.0mmn, Implant 6.0mm x 8.0mm,

Implant 6.0mm x 10O.0mm, Implant 7.0 x 6.0, Implant 7.0mm x 8.0mm, Implant

-ILI

8.Omm x I10.0mm;

b) KAT Implant System Straight (Prepable) Abutments 4.2mmn x 6.5mm, 4.6mm x

6.5mmn, 5.0mm x 6.5mm, 5.4mmn x 6.5mm, 6.4mm x 6.5mm;

are substantially equivalent to the noted predicate devices based on tabulated device

specifications' and properties presented in the Summary of Technological Characteristics.

These proposed devices are substantially equivalent to the predicate devices because they

have:

- same fundamental scientific technology and intended use as the predicate device;

- same materials, processing, packaging, sterilization and inspection methods;

- same manufacturing infrastructures (both human and physical);

- same instructions for use.

Page 12: CDRH- DMC 1 · nitric acid passivation per ASTM F86-04, Standard Practice for Surface Preparation and Marking of Metallic Surgical Implants); d) packaged with the same size and material

DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service

vfloFood and Drug Adinirstation10903 Ne'v Hampshire AvenueDocument Control Room -WV066-C,609Silver Spring, MD 20993-0002

Vitali Bondar, DDSChief Executive OfficerRAT Implants, LLC15 Rye Street, Suite 115Portsmouth, New Hampshire 03801AP i321

Re: K101201Trade/Device Name: KAT Implant System Dental Implant 6.0mmn x 6.0rm DentalImplant 6.0mm x 8.0mm; Dental Implant 6.0mmn x 1 0.0mm; Dental Implant 7.0mm x6.0mm; Dental Implant 7.0mmn x 8.0mm; Dental Implant 7.0mm x 1 0.0mm; DentalImplant 8.0mm x 6.0nm; Dental Implant 8.0mm x 8.0mm; Dental Implant 8.0mm x10.0mm & KAT Implant System Straight (Prepable) Abutments 4.2mm x 6.5mm,Straight (Prepable) Abutments 4.6mnm x 6.5mm, Straight (Prepable) Abutments5.0mm x 6.5mim, Straight (Prepable) Abutments 5.4mm x 6.5mm, Straight (Prepable)

Abutments 6.4mm x 6.5.mmRegulation Number: 21 CFR 872.3640Regulation Name: Endosseous Dental ImplantRegulatory Class: 11Product Code: DZEDated: January 31, 2011Received: January 3 1, 2011

Dear Dr. Bondar:

We have reviewed your Section 5 1 0(k) premrarket notification of intent to market the devicereferenced above and have determined the device is substantially equivalent (for theindications for use stated in ihe enclosure) to legally marketed predicate devices marketed ininterstate commerce prior to May 28, 1976, the enactment date of the Medical DeviceAmendments, or to devices that have been reclassified in accordance with the provisions ofthe Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarketapproval application (PMA). You may, therefore, market the device, subject to the generalcontrols provisions of the Act. The general controls provisions of the Act includerequirements for annual registration, listing of devices, good manufacturing practice,labeling, and prohibitions against misbranding and adulteration. Please note: CDRH doesnot evaluate information related to contract liability warranties. We remind you, however,that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class [1 (Special Controls) or class IIl(PMA), it may be subject to additional controls. Existing nmajor regulations affecting yourdevice can be found in the Code of Federal Regulations, Title 2 1, Parts 800 to 898. Inaddition, FDA may publish further announcements concerning your device in the FederalRegister.

___

Page 13: CDRH- DMC 1 · nitric acid passivation per ASTM F86-04, Standard Practice for Surface Preparation and Marking of Metallic Surgical Implants); d) packaged with the same size and material

Page 2- Dr. Bondar

Please be advised that FDA's issuance of a substantial equivalence determination does notmean that FDA has made a determination that your device complies with other requirementsof the Act or any Federal statutes and regulations administered by other Federal agencies.You must comply with all thle Act's requirements, including, but not limited to: registrationand listing (21 CER Part 807),:labeling (21 CFR Part 801); medical device reporting(reporting of medical device-related adverse events) (21 CFR 803); good manufacturingpractice requirements as set forth in the quality systems (QS) regulation (21 CFR Pant 820);and if applicable, the electronic product radiation control provisions (Sections 531t-542 ofthe Act); 21 CFR 1000- 1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801),please go to htp/v,".d~o/buFACnesfie/D~/DI~fcsucml 15809.htm for the Center for Devices and Radiological Health's (CDRH's) Office ofCompliance. Also, please note the regulation entitled, "Misbranding by reference topremarket notification" (2 1 CFR Part 807.97). For questions regarding the reporting ofadverse events under the MDR regulation (21 CFR Part 803), please go tohtp/wwfaRvMdcleie/Sft/eo-arbe/eal~t for the CDRH'sOffice of Surveillance and B iometrics/Di vision of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from theDivision of Small Manufacturers, International and Consumer Assistance at its toll-freenumber (800) 638-2041 or (301) 796-7100 or at its Internet addresshtp/wwfagvMdcleie/eorefro/nutydfuthm

Sincerely yours,

Anthony D. Watson, 8.S., M.S., M.B.A.Division DirectorDivision of Anesthesiology, General H-ospital,

Infection Control and Dental DevicesOffice of Device EvaluationCenter for Devices and

Radiological Health

Enclosure

Page 14: CDRH- DMC 1 · nitric acid passivation per ASTM F86-04, Standard Practice for Surface Preparation and Marking of Metallic Surgical Implants); d) packaged with the same size and material

Indications for Use Statement

510(k) Number: K(101201

Device Name:

KAT Implant System Dental Implant 6.0mm x 6.0mm; Dental Implant 6.0mm x 8.0mmn;Dental Implant 6.0mmn x I10.0mm; Dental Implant 7.0mmn x 6.0mm; Dental Implant7.0mm x 8.0mmn; Dental Implant 7.0mmn x 10O.0mm; Dental Implant 8.0mmr x 6.0mm;Dental Implant 8.0mmn x 8.0mmn; Dental Implant-8.Omm x 1 0.0rm

KAT Implant System Straight (Prepable) Abutments 4.2mm x 6.5mm, Straight(Prepable) Abutments 4.6mm x 6.5mm, Straight (Prepable) Abutments 5.0mm x 6.5mim,Straight (Prepable) Abutments 5.4mm x 6.5mm, Straight (Prepable) Abutments 6.4mm x6.5mm

Indications for Use:

KAT Implant System dental implants and abutments are indicated for restoration ofedentulous maxilla and mandible, to provide support for removable dentures, fixedbridges, or to be used as a single tooth replacement. Single or splinted implants can beimmediately loaded if good primary stability and appropriate occlusal loading areachieved. The implants can be placed in extraction sites or healed alveolar ridges.Immediate loading may not be appropriate in Type IV bone due to difficulty in achievingprimary stability.

Prescription Use x AND/OR Over-The-Counter Use ___

(Part 21 CFR 801 Subpart D) .. (21 CFR 801 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGEOF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Page 1 of_

(Division Sign-Off)Division of Anesthesiology, General Hospitali1fection Control, Dental Devices

Ml(k) Number: 1 o& h

3